Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 4, Issue 1 , Pages 22-29 , January 2008

Prognosis of Alzheimer’s disease today: A two-year prospective study in 686 patients from the REAL-FR Study

  • Frédéric Cortes

      Affiliations

    • Department of Internal Medicine and Clinical Gerontology, Centre Hospitalier Universitaire Purpan-Casselardit, Toulouse, France
    • Inserm U558, Toulouse, France
    • Corresponding Author InformationCorresponding author. Tel.: 33-5-61-77-76-06; Fax: 33-5-61-77-25-93.
    • ,
  • Fati Nourhashémi

      Affiliations

    • Department of Internal Medicine and Clinical Gerontology, Centre Hospitalier Universitaire Purpan-Casselardit, Toulouse, France
    • Inserm U558, Toulouse, France
    • ,
  • Olivier Guérin

      Affiliations

    • Department of Gerontology, University Hospital, Nice, France
    • ,
  • Christelle Cantet

      Affiliations

    • Department of Internal Medicine and Clinical Gerontology, Centre Hospitalier Universitaire Purpan-Casselardit, Toulouse, France
    • Inserm U558, Toulouse, France
    • ,
  • Sophie Gillette-Guyonnet

      Affiliations

    • Department of Internal Medicine and Clinical Gerontology, Centre Hospitalier Universitaire Purpan-Casselardit, Toulouse, France
    • Inserm U558, Toulouse, France
    • ,
  • Sandrine Andrieu

      Affiliations

    • Inserm U558, Toulouse, France
    • Department of Epidemiology and Public Health, Toulouse, France
    • ,
  • Pierre-Jean Ousset

      Affiliations

    • Department of Internal Medicine and Clinical Gerontology, Centre Hospitalier Universitaire Purpan-Casselardit, Toulouse, France
    • ,
  • Bruno Vellas

      Affiliations

    • Department of Internal Medicine and Clinical Gerontology, Centre Hospitalier Universitaire Purpan-Casselardit, Toulouse, France
    • Inserm U558, Toulouse, France
    • ,
  • REAL-FR Group

References 

  1. Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, et al. AD 2000 Collaborative Group. long term donepezil treatment in 565 patients with Alzheimer’s disease (AD 2000)—randomised double blind trial. Lancet. 2004;363:2105–2115
  2. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34:939–944
  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed.. Washington, DC: APA; 1994;
  4. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, Cantet C, Micas M, Ousset PJ, et al. REAL.FR group: the REAL.FR research program on Alzheimer’s disease and its management: methods and preliminary results. J Nutr Health Aging. 2003;7:91–96
  5. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198
  6. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry. 1984;141:1356–1364
  7. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. The index of ADL: A standardized measure of biological and psychosocial function. JAMA. 1963;185:914–919
  8. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308–2314
  9. Vellas B, Guigoz Y, Garry PJ, Nourhashemi F, Bennahum D, Lauque S, et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition. 1999;2:116–122
  10. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566–572
  11. Mohs RC, Schmeidler J, Aryan M. Longitudinal studies of cognitive, functional and behavioural changes in patients with Alzheimer’s disease. Stat Med. 2000;19:1401–1409
  12. Miliken JK, Edland SD. Mixed effect models of longitudinal Alzheimer’s data: a cautionary note. Stat Med. 2000;19:1617–1629
  13. Cortes F, Gillette-Guyonnet S, Nourhashemi F, Andrieu S, Cantet C, Vellas B. Recent data on the natural history of Alzheimer’s disease: results from the REAL.FR Study. J Nutr Health Aging. 2005;9:86–93
  14. Dumont C, Voisin T, Nourhashemi F, Andrieu S, Koning M, Vellas B. Predictive factors for rapid loss on the mini-mental state examination in Alzheimer’s disease. J Nutr Health Aging. 2005;9:163–167
  15. Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): part IV—rates of cognitive change in the longitudinal assessment of probable Alzheimer’s disease. Neurology. 1993;43:2457–2465
  16. Stern RG, Mohs RC, Davidson M, Schmeidler J, Silverman J, Kramer-Ginsberg E, et al. A longitudinal study of Alzheimer’s disease: measurement, rate and predictors of cognitive deterioration. Am J Psychiatry. 1994;151:390–396
  17. Green CR, Mohs RC, Schmeidler J, Aryan M, Davis KL. Functional decline in Alzheimer’s disease: a longitudinal study. J Am Geriatr Soc. 1993;41:654–661
  18. Mega MS, Masterman DM, O’Connor SM, Barclay TR, Cummings JL. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer’s disease. Arch Neurol. 1999;56:1388–1393
  19. Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioral changes in Alzheimer’s disease. Neurology. 1996;46:130–135
  20. Landes AM, Sperry SD, Strauss ME, Geldmacher DS. Apathy in Alzheimer’s disease. J Am Geriatr Soc. 2001;49:1700–1707
  21. Vellas B, Lauque S, Gillette-Guyonnet S, Andrieu S, Cortes F, Nourhashemi F, et al. Impact of nutritional status on the evolution of Alzheimer’s disease and on response to acetylcholinesterase inhibitor treatment. J Nutr Health Aging. 2005;9:75–80
  22. Gillette-Guyonnet S, Andrieu S, Cortes F, Nourhashemi F, Cantet C, Ousset PJ, et al. Outcome of Alzheimer’s disease: potential impact of cholinesterase inhibitors. J Gerontol A Biol Sci Med Sci. 2006;61:516–520
  23. Massoud F, Devi G, Stern Y, Lawton A, Goldman JE, Liu Y, et al. A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia. Arch Neurol. 1999;56:1368–1373

PII: S1552-5260(07)00633-4

doi: 10.1016/j.jalz.2007.10.018

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 4, Issue 1 , Pages 22-29 , January 2008

Article Tools

* Image Usage & Resolution